Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Din
Chuen-Lin Din, Taipei City TW
| Patent application number | Description | Published |
|---|---|---|
| 20110171302 | METHOD FOR TREATING NEURODEGENERATIVE DISORDERS WITH ORAL DOSAGE FORMULATION CONTAINING BOTH IMMEDIATE-RELEASE AND SUSTAINED-RELEASE DRUGS - Disclosed herein is a method for treating patient suffering from a disorder related to central nervous system with an oral dosage formulation that contains both sustained-release and immediate-release drugs. The sustained-release drug in the oral dosage formulation is memantine, and the formulation provides an average blood level C | 07-14-2011 |
Chunming Din, Singapore SG
| Patent application number | Description | Published |
|---|---|---|
| 20120028838 | Quantification of Gene Expression - The present invention relates to a method for measuring the amount of a target nucleic acid in a sample using a standard which is designed to have one base difference compared with the gene of interest or a “target nucleic acid sequence.” Use of such standard in combination with a method of “enhancing” the difference in the standard and the test nucleic acid sample using, for example, a base extension reaction carried right at the mutation site allowing amplification of the standard and target nucleic acids with the same efficiency and facilitating quantification of the target nucleic acid. Thereafter a means of quantifying the “enhanced” standard and target nucleic acid samples is used to determine the amount of the target nucleic acid. In the preferred embodiment, the quantification means is Mass Spectrometry. | 02-02-2012 |
Imad Ud Din, Lund SE
| Patent application number | Description | Published |
|---|---|---|
| 20080278277 | Digitally controllable on-chip resistors and methods - A digitally controllable resistor includes a substrate and at least one digitally controllable resistance stage formed on the substrate. Each of the stage(s) can include a first resistor connected in series with a switch and a second resistor connected in parallel with the first resistor and the switch. Each stage can also include a control line connected to the switch for opening and closing the switch in response to a control bit associated therewith. Multiple resistance stages can be connected in series and the digitally controllable variable resistor can be integrated onto a substrate. | 11-13-2008 |
| 20110136455 | Signal Processing Device and Method - A processing device ( | 06-09-2011 |
Salah U. Din, Austin, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20110012895 | Processing Hogel Data - Methods and systems for processing hogel data including providing a set of hogel data, providing one or more properties of a hogel light modulator, and processing the set of hogel data according to the one or more properties of the hogel display. | 01-20-2011 |
Tien Whei Din, Carson, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100215204 | SPEAKER ISOLATION SYSTEM - A loudspeaker mounting assembly for mounting a loudspeaker in an isolated relation to a structure includes an enclosure and a plurality of interface elements composed of a vibration-damping material. The enclosure has an interior for receiving the loudspeaker and includes at least two spaced-apart support members. Each of the at least two support members includes a support member outer surface and an inner surface extending from the support member outer surface into the support member. The inner surface defines a support member bore. Each interface element includes an interface element outer surface. Each interface element is disposed in a corresponding one of the support member bores and at least partially extends out from the respective support member outer surface, where each interface element outer surface contacts the respective inner surface of the support member. | 08-26-2010 |
Wanwan S. Din, Issaquah, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20090081700 | Methods of use of the TACI/TACI-L interaction - The invention discloses a novel interaction between a TNF receptor (TACI) and its interacting ligand (TACI-L). Also disclosed are methods of screening candidate molecules to determine potential antagonists and agonists of the TACI/TACI-L interaction. The use of the antagonists and agonists as therapeutics to treat autoimmune diseases, inflammation, and to inhibit graft vs. host rejections is further disclosed. | 03-26-2009 |
| 20100196404 | METHODS OF USE OF THE TACI/TACI-L INTERACTION - The invention discloses a novel interaction between a TNF receptor (TACI) and its interacting ligand (TACI-L). Also disclosed are methods of screening candidate molecules to determine potential antagonists and agonists of the TACI/TACI-L interaction. The use of the antagonists and agonists as therapeutics to treat autoimmune diseases, inflammation, and to inhibit graft vs. host rejections is further disclosed. | 08-05-2010 |